Clinical Trial Update: Intralesional Chemotherapy (IC): Cisplatin + Epinephrine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for intralesional chemotherapy using cisplatin plus epinephrine in laryngeal squamous cell carcinoma, currently not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• EPINEPHRINE (EPINEPHRINE)

Snippet

Sponsor: University of Miami | Conditions: Laryngeal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING